Periodontal Healing After Application of Enamel Matrix Derivative in Surgical Supra Infrabony Periodontal Defects in Rates with Streptozotocin-Induced Diabetes
Background and Objective: Epidemiologic and clinical studies have indicated that
diabetes is a risk factor for periodontal disease progression and healing. The
aim of the present study was to evaluate short-term healing after enamel matrix
derivative (EMD) application in combined supra/infrabony periodontal defects
in diabetic rats.
Material and Methods: Thirty male Wistar rats were initially divided into two
groups, one with streptozotocin-induced diabetes and another one with healthy
(non-diabetic) animals. Bony defects were surgically created on the mesial root
of the first maxillary molars. After root surface planing and EDTA conditioning,
EMD was applied to the roots at one side of the maxillae, while those on
the contralateral sides were left untreated. Animals were killed 3 wk after surgery,
and block sections were prepared for histologic and histomorphometric
analysis.
Results: There was statistically significant more gingival recession in diabetic
animals than in non-diabetic animals. The length of the junctional epithelium
was significantly shorter in the EMD-treated sites in both diabetic and normoglycemic
rats. Sulcus depth and length of supracrestal soft connective tissue
showed no statistically significant differences between groups. In all animals,
new bone formation was observed. Although new bone occurred more frequently
in healthy animals, the extent of new bone was not significantly different
between groups. In none of the teeth, a layer of new cementum was detectable.
EMD had no influence on bone or cementum regeneration. Adverse reactions
such as excessive inflammation due to bacterial root colonization, ankylosis and
bone fractures were exclusively observed in diabetic animals, irrespective of
EMD treatment.